Diagnosis of conjunctival B-cell lymphoma by polymerase chain reaction heteroduplex analysis

Erich C Strauss1, John F Warren, Todd P Margolis

  • 1Department of Ophthalmology, University of California San Francisco Medical Center, California, San Francisco, USA. strauss@itsa.ucsf.edu

Insights

Polymerase chain reaction heteroduplex analysis diagnosed conjunctival B-cell lymphoma when histology was inconclusive. This molecular technique differentiates benign lymphoid hyperplasia from low-grade lymphoma in ocular adnexa.

Area of Science:

  • Ophthalmology
  • Oncology
  • Molecular Diagnostics

Background:

  • Giant papillary conjunctivitis can mimic other conjunctival conditions.
  • Distinguishing benign lymphoid hyperplasia from low-grade B-cell lymphoma is clinically significant.
  • Molecular techniques offer potential for improved diagnostic accuracy.

Observation:

  • A case of unilateral blepharoptosis secondary to an extensive palpebral conjunctival follicular-like process was observed.
  • Initial clinical and histological assessment suggested benign lymphoid hyperplasia.
  • Immunohistochemical studies were also consistent with benign lymphoid hyperplasia.

Findings:

  • Polymerase chain reaction heteroduplex analysis identified low-grade B-cell lymphoma.
  • This molecular finding contrasted with the histological and immunohistochemical results.
  • The patient received focal radiation therapy with no signs of lymphoma on preliminary follow-up.

Implications:

  • Polymerase chain reaction heteroduplex analysis can diagnose conjunctival B-cell lymphoma even without supportive histological or immunohistochemical evidence.
  • This molecular technique provides a method for independent diagnostic distinction between benign lymphoid hyperplasia and low-grade B-cell lymphoma of the ocular adnexa.
  • This advancement may lead to earlier and more accurate diagnosis and treatment of ocular adnexal lymphomas.
Abstract

Related Concept Videos